2022-10-06T09:28:22-00:00 2021-12-31 135381590 BDO USA LLP 8401 Greensboro Drive Suite 800 McLean VA 22102 990 2021-01-01 541734511 American Diabetes Association Research Foundation Inc AMER 7035491500 2451 Crystal Drive Suite 900 Arlington VA 22202 Charlotte M Carter Chief Financial Officer 7035491500 2022-10-06 true Charlotte Carter XXX-XX-XXXX Marc Berger P01871563 7038930600 2022-10-06 2 AAL1 IAL1 2021 2022-09-23 18:48:47Z X Charles D Henderson 2451 Crystal Dr Suite 900 Arlington VA 22202 9794159 false 3326 X www.diabetes.org/news-research X 1994 VA The American Diabetes Association Research Foundation, Inc. the Foundation secures major gifts and grants to fund diabetes-related research. Please see complete mission statement in Schedule O X 9 9 0 63 0 9866077 9787622 0 6537 0 9866077 9794159 16064785 16216251 0 0 0 451756 517290 722809 16582075 16939060 -6715998 -7144901 18545687 0 3575966 0 14969721 0 X The Foundation was founded to give focus to the American Diabetes Associations research program and to ensure the availability of funds to support research. false true 16216251 16216251 Research Continued on Sch. O 16216251 true true false false false false false false false false false false false false false true true true false false false false false false false false false true true true false false false false true false false false false false true false false true false true false true 0 0 0 false false false false false false false false false false false false X 9 9 true true false false false true true true true false false true true true true true true false false false AK AL AR AZ CA CO CT DC FL GA HI IL KS KY LA MA MD ME MI MN MO MS NC ND NJ NV NY OH OK OR PA PR RI SC TN UT VA WA WI WV X Charlotte M Carter CFO 7035491500 2451 Crystal Drive Suite 900 Arlington VA 22202 X Tracey D Brown through October 6 20 Chief Executive Officer 000.10 037.40 X 0 1047921 138575 Robert A Gabbay Chief Scientific Medical Officer and Office of the CEO 000.10 037.40 X 0 457210 42390 Charlotte M Carter Chief Financial Officer and Office of the CEO 000.10 037.40 X 0 324015 29537 Charles D Henderson Chief Development Officer and Office of the CEO 000.10 037.40 X 0 294338 16308 Karen Talmadge PhD through October Vice Chair of the Board 000.10 X X 0 0 0 Pearson C Cummin III MBA through Oc Secretary-Treasurer 000.10 X X 0 0 0 Ruth Weinstock effective October 25 Chair of the Board 000.10 006.20 X X 0 0 0 Matthew Rifkin through October 25 2 Board of Directors 000.10 X 0 0 0 Tim Erblich through October 25 2021 Board of Directors 000.10 X 0 0 0 George J Huntley CPA through Octobe Board of Directors 000.10 X 0 0 0 James A Horbowicz through October 2 Board of Directors 000.10 X 0 0 0 Alan Altschuler through October 25 Board of Directors 000.10 X 0 0 0 Al Powers through October 25 2021 Board of Directors 000.10 X 0 0 0 Edward T Hawthorne through October Board of Directors 000.10 X 0 0 0 John W Griffin Jr JD through Octobe Board of Directors 000.10 X 0 0 0 Umesh Verma Board of Directors 000.10 001.00 X 0 0 0 Orville G Kolterman MD through Octo Board of Directors 000.10 X 0 0 0 Linda Cummin through October 25 202 Board of Directors 000.10 X 0 0 0 Desmond Schatz MD through October 2 Board of Directors 000.10 X 0 0 0 John E Anderson MD through October Board of Directors 000.10 X 0 0 0 Geralyn R Spollet MSN ANP-CS CDE th Board of Directors 000.10 X 0 0 0 James W Quinn JD through October 25 Board of Directors 000.10 X 0 0 0 Donald J Wagner through October 25 Board of Directors 000.10 X 0 0 0 Martha Parry Clark effective Octobe Board of Directors 000.10 001.00 X 0 0 0 Guillermo Umpierrez effective Octob Board of Directors 000.10 002.20 X 0 0 0 Cynthia E Munoz effective October 2 Board of Directors 000.10 006.20 X 0 0 0 Stephanie Silverman effective Octob Board of Directors 000.10 001.00 X 0 0 0 Amparo Gonzalez effective October 2 Board of Directors 000.10 001.00 X 0 0 0 Rone Luczynski effective October 25 Board of Directors 000.10 001.00 X 0 0 0 Mary de Groot effective October 25 Board of Directors 000.10 001.00 X 0 0 0 2123484 226810 false true false NA 73488 6220482 3493652 9787622 6537 6537 9794159 6537 16198251 16198251 18000 18000 0 0 0 0 0 0 0 0 722809 271053 451756 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16939060 16216251 271053 451756 270594 18179378 95715 18545687 0 3575966 3575966 0 X 14969721 14969721 0 18545687 0 X -7144901 6237 -7831057 X false true X true false X 35119963 16438956 20934789 9866077 9787622 92147407 35119963 16438956 20934789 9866077 9787622 92147407 92147407 3514 4009 7816 6537 21876 92169283 0.99980 0.99980 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false Financial derivatives and other financial products Closely-held equity interests Federal income taxes X 9824810 6237 24414 30651 9794159 9794159 16390736 24414 -572738 -548324 16939060 16939060 X 2 The following was disclosed related to uncertain tax position in the audited financial statements. The American Diabetes Association Research Foundation, Inc. the Foundation is generally exempt from income taxes under section 501c3 of the Internal Revenue Code the Code and charitable contributions to the Foundation qualify for charitable tax deductions as described in the Code. The Foundation is subject to taxation on any net unrelated business income and has been classified as an organization that is not a private foundation under Section 509a of the Code. The Foundation recognizes the effect of income tax positions only if those positions more likely than not would not be sustained upon examination by the Internal Revenue Service. The Foundation has analyzed the tax positions taken and has concluded that as of December 31, 2021, there are no uncertain tax positions taken or expected to be take that would require recognition of a liability or asset or disclosure in the financial statements. XII 2 Prior Year Research Grants Awards/Forfeitures 572,738. true University of Connecticut School of Nursing 231 Glenbrook Road Storrs CT 06269 060772160 115 200000 Innovative Clinical or Translational Science New Health Disparities University of Washington 1201 Larimer Street Seattle WA 99164 916001108 501c3 200000 Innovative Clinical or Translational Science New Health Disparities The University of North Carolina at Chapel Hill 104 Airport Dr Ste 2200 CD1350 Chapel Hill NC 27157 223849199 501c3 199993 Innovative Clinical or Translational Science New Health Disparities Kaiser Permanente Northern California One Kaiser Plaza Oakland CA 94612 941340523 501c3 199977 Innovative Clinical or Translational Science New Health Disparities California Polytechnic State University 1 Grand Avenue San Luis Obispo CA 93407 204927897 501c3 190000 Innovative Clinical or Translational Science Broad Institute Inc 415 Main Street Cambridge MA 02142 263428781 501c3 190000 Innovative Clinical or Translational Science Stanford University 3145 Porter Drive Palo Alto CA 93407 204927897 501c3 190000 Innovative Clinical or Translational Science University of Miami School of Medicine PO Box 025405 Miami FL 33102 590624458 501c3 190000 Innovative Clinical or Translational Science Medical College of Wisconsin 8701 Watertown Plank Rd Milwaukee WI 53226 390806261 501c3 190000 Innovative Clinical or Translational Science Arizona Board of Regents University of Arizona 2700 N Central Ave Suite 850 Phoenix AZ 85004 742652689 170c1 190000 Innovative Clinical or Translational Science The Board Of Trustees Of The University Of Illinois 506 S Wright Street 209 HAB NO MC33 Urbana IL 61801 376000511 501c3 189999 Innovative Clinical or Translational Science Benaroya Research Institute at Virginia Mason 1201 Ninth Avenue Seattle WA 98101 910653422 501c3 189995 Innovative Clinical or Translational Science University of Utah 201 South Presidents Circle Rm 406 Salt Lake City UT 84112 876000525 501c3 186708 Innovative Clinical or Translational Science George Washington University 1922 F Street NW Washington DC 20052 530196584 501c3 185504 Innovative Clinical or Translational Science New Health Disparities The Board of Regents of the University of Wisconsin System 21 N Park Street Suite 6401 Madison WI 53226 390806261 501c3 184325 Innovative Clinical or Translational Science New Health Disparities Ann and Robert H Lurie Children's Hospital of Chicago 225 E Chicago Ave Chicago IL 60611 362170833 501c3 175593 Innovative Clinical or Translational Science New Health Disparities Case Western Reserve University 10900 Euclid Avenue Cleveland OH 45701 316402269 501c3 137907 Innovative Clinical or Translational Science New Health Disparities Regents Of The University Of Michigan 3003 S State St Rm 1054 Ann Arbor MI 48202 386028429 501c3 131100 Junior Faculty University of Iowa 4 Jessup Hall Room B5 Iowa City IA 52242 426004813 115 131100 Junior Faculty Trustees of Indiana University PO Box 500 Bloomington IN 47402 356018940 501c3 131100 Junior Faculty The Board of Trustees of the Leland Stanford Junior University 450 Serra Mall Stanford CA 941432212 680000845 501c3 131100 Junior Faculty Development Duke University 324 Blackwell St Washington Bldg Durham NC 27599 566001393 501c3 131100 Junior Faculty Development University of Pittsburgh School of Medicine 116 Atwood Street Suite 201 Pittsburgh PA 15261 250965591 501c3 131100 Junior Faculty Development Ohio Department of Health Bureau of Maternal Child and Family Health 246 N High Street 6th Floor Columbus OH 43215 311334820 501a 131100 Junior Faculty Development City of Hope Beckman Research Institute 1500 East Duarte Road Duarte CA 94305 941156365 501c3 131100 Junior Faculty Development Georgia State University Research Foundation Inc 33 Gilmer Street SE Atlanta GA 30303 581845423 501c3 131100 Junior Faculty Development The University of North Carolina at Chapel Hill 104 Airport Dr Ste 2200 CD1350 Chapel Hill NC 27157 223849199 501c3 131100 Junior Faculty Development University of Texas Southwestern Medical Center at Dallas PO Box 841753 Dallas TX 77840 742245072 501c3 131100 Junior Faculty Development Texas A&M University System HSC 401 George Bush Drive College Station TX 77840 742245072 501c3 131099 Junior Faculty Development Wayne State University School of Medicine 5057 Woodward Avenue 13th floor Sui Detroit MI 48202 386028429 501c3 131095 Junior Faculty Development Medical College of Wisconsin 8701 Watertown Plank Rd Milwaukee WI 53226 390806261 501c3 130317 Junior Faculty Development University Of Pittsburgh 116 Atwood Street Suite 201 Pittsburg PA 15261 250965591 501c3 127558 Junior Faculty Development Colorado School of Mines 1500 Illinois Street Golden CO 80401 846000551 501c3 122311 Junior Faculty Partners Healthcare System Inc 399 Revolution Dr Ste 645 Somerville MA 021451465 042103561 501c3 116781 Junior Faculty The Regents of the University of California Los Angeles 10920 Wilshire Blvd Ste 620 Los Angeles CA 941432212 680000845 501c3 109250 Innovative Basic Science Regents of the University of Minnesota 450 McNamara Alumni Center Minneapolis MN 55414 415007513 170c1 109250 Innovative Basic Science Regents of the University of California 1111 Franklin Street 10th Floor Oakland CA 92093 956006144 501c3 109250 Innovative Basic Science Yale University 155 Whitney Avenue Room 230 PO Box New Haven CT 06510 060646973 501c3 109250 Innovative Basic Science Memorial Sloan Kettering Cancer Center 1275 York Avenue New York NY 10461 131624225 501c3 109250 Innovative Basic Science The Ohio State University 1960 Kenny Road Columbus OH 45701 316402269 501c3 109250 Innovative Basic Science The University of Texas Health Science Center at San Antonio 7703 Floyd Curl Drive San Antonio TX 77030 741613878 501c3 109250 Innovative Basic Science Temple University of the Commonwealth System of Higher Education 3333 N Broad Street Philadelphia PA 15260 250965591 501c3 109250 Innovative Basic Science Regents Of The University Of Michigan 3003 S State St Rm 1054 Ann Arbor MI 48202 386028429 501c3 109250 Innovative Basic Science Louisiana State University Health Sciences Center New Orleans 433 Bolivar Street New Orleans LA 70112 726087770 501c3 109250 Innovative Basic Science Universidad Central del Caribe PO Box 60327 Bayamon PR 00960 660349669 501c3 109250 Innovative Basic Science University of Colorado at Boulder 3100 Marine Street Boulder CO 80208 840404231 501c3 109250 Innovative Basic Science Vanderbilt University Medical Center 3319 West End Avenue Ste 800 Nashville TN 37203 620476822 501c3 109250 Innovative Basic Science The University of Toledo Health Science Campus 2801 West Bancroft Street Toledo OH 44106 341018992 501c3 109236 Innovative Basic Science Board of Regents of the University of Wisconsin System 21 N Park Street Suite 6401 Madison WI 53226 390806261 501c3 109117 Innovative Basic Science University of Colorado Denver 1800 Grant Street Suite 600 Denver CO 80203 846000555 501c3 108397 Innovative Basic Science Southern Illinois University School of Medicine PO Box 19620 Springfield IL 62794 376005961 501c3 108012 Innovative Basic Science University of Washington 1201 Larimer Street Seattle WA 99164 916001108 501c3 98055 Innovative Basic Science Children's Research Institute 111 Michigan Ave NW Washington DC 20010 521654453 501c3 68608 Postdoctoral Fellowship Health Disparities Award Joslin Diabetes Center Inc One Joslin Place Boston MA 01655 043167352 115 67743 Mentor-Based Postdoctoral Fellowship Baylor College of Medicine One Baylor Plaza Houston TX 75284 756002868 170c1 67743 Postdoctoral Fellowship The Regents of the University of California San Francisco 3333 California Street Ste 315 San Francisco CA 910103012 953432210 501c3 67743 Postdoctoral Fellowship University of Iowa 4 Jessup Hall Room B5 Iowa City IA 52242 426004813 115 67743 Minority Postdoctoral Fellowship PMF University of Colorado 1800 Grant Street Suite 600 Denver CO 80203 846000555 501c3 67500 ADA-Pfizer Fellowship Award University of Alabama at Birmingham 1530 3rd Ave South AB 990 Birmingham AL 35294 636005396 501c3 66793 Postdoctoral Fellowship The Regents of the University of California 2200 University Avenue Berkeley CA 941432212 680000845 501c3 65645 Postdoctoral Fellowship The Regents of the University of Michigan 3003 South State Street Ann Arbor MI 48109 386028429 501c3 65645 Postdoctoral Fellowship Cincinnati Children's Hospital Medical Center 3333 Burnet Avenue MLC 9002 Cincinnati OH 43210 316025986 501c3 65645 Minority Postdoctoral Fellowship PMF Cincinnati Children's Hospital Medical Center 3333 Burnet Avenue MLC 9002 Cincinnati OH 43210 316025986 501c3 65553 Postdoctoral Fellowship The Regents of the University of Michigan 3003 South State Street Ann Arbor MI 48109 386028429 501c3 65170 Postdoctoral Fellowship Partners Healthcare System Inc 399 Revolution Dr Ste 645 Somerville MA 021451465 042103561 501c3 64144 Postdoctoral Fellowship Health Disparities Award Ann and Robert H Lurie Children's Hospital of Chicago 225 E Chicago Ave Chicago IL 60611 362170833 501c3 63760 Postdoctoral Fellowship Health Disparities Award Beth Israel Deaconess Medical Center Inc 330 Brookline Ave Boston MA 02115 042774441 501c3 63536 Mentor-Based Postdoctoral Fellowship The Rockefeller University 1230 York Avenue New York NY 10065 131924236 501c3 63536 Postdoctoral Fellowship University of Michigan 3003 S State St Rm 1054 Ann Arbor MI 48202 386028429 501c3 63536 Postdoctoral Fellowship University Of Pittsburgh 116 Atwood Street Suite 201 Pittsburg PA 15261 250965591 501c3 63536 Postdoctoral Fellowship The Board of Trustees of the University of Illinois 506 S Wright Street 209 HAB NO MC33 Urbana IL 61801 376000511 501c3 63536 Postdoctoral Fellowship Beth Israel Deaconess Medical Center Inc 330 Brookline Ave Boston MA 02115 042774441 501c3 63536 Minority Postdoctoral Fellowship PMF Trustees of Columbia University in the City of New York 615 West 131st Street MC 8741 New York NY 10065 131924236 501c3 63536 Minority Postdoctoral Fellowship PMF Sanford Burnham Prebys Medical Discovery Institute 10901 North Torrey Pines Road La Jolla CA 92037 952160097 501c3 61518 Postdoctoral Fellowship Harvard Medical School 1033 Massachusetts Ave Third Floor Cambridge MA 01655 043167352 115 61518 Mentor-Based Postdoctoral Fellowship Washington University 700 Rosedale Avenue Saint Louis MO 631121408 430653611 501c3 61518 Mentor-Based Postdoctoral Fellowship University of Michigan 3003 S State St Rm 1054 Ann Arbor MI 48202 386028429 501c3 61518 Mentor-Based Minority Postdoctoral Fellowship Adventist Health SystemSunbelt Inc dba Florida Hospital 900 Hope Way Altamonte Springs FL 33102 590624458 501c3 61518 Postdoctoral Fellowship The Regents of the University of California Los Angeles 10920 Wilshire Blvd Ste 620 Los Angeles CA 941432212 680000845 501c3 61518 Postdoctoral Fellowship University of Michigan 3003 S State St Rm 1054 Ann Arbor MI 48202 386028429 501c3 61518 Postdoctoral Fellowship University of Iowa 4 Jessup Hall Room B5 Iowa City IA 52242 426004813 115 61518 Postdoctoral Fellowship The Children's Hospital of Philadelphia 3401 Civic Center Blvd Philadelphia PA 19104 231352685 501c3 61518 Postdoctoral Fellowship President and Fellows of Harvard College 1033 Massachusetts Ave Third Floor Cambridge MA 01655 043167352 115 61518 Minority Postdoctoral Fellowship PMF University of Massachusetts 333 South St Ste 450 Shrewsbury MA 02115 042774441 501c3 61518 Minority Postdoctoral Fellowship PMF University of Washington 1201 Larimer Street Seattle WA 99164 916001108 501c3 60567 Postdoctoral Fellowship University of Texas Southwestern Medical Center at Dallas PO Box 841753 Dallas TX 77840 742245072 501c3 59751 Mentor-Based Postdoctoral Fellowship Duke University 324 Blackwell St Washington Bldg Durham NC 27599 566001393 501c3 59751 Postdoctoral Fellowship The University of Texas Health Science Center at San Antonio 7703 Floyd Curl Drive San Antonio TX 77030 741613878 501c3 59751 Minority Postdoctoral Fellowship PMF Trustees of Columbia University in the City of New York 615 West 131st Street MC 8741 New York NY 10065 131924236 501c3 57722 Mentor-Based Minority Postdoctoral Fellowship Joslin Diabetes Center Inc One Joslin Place Boston MA 01655 043167352 115 57357 Mentor-Based Postdoctoral Fellowship Board of Regents of the University of Wisconsin System 21 N Park Street Suite 6401 Madison WI 53226 390806261 501c3 57357 Mentor-Based Postdoctoral Fellowship Duke University 324 Blackwell St Washington Bldg Durham NC 27599 566001393 501c3 50760 ADA-Pfizer Fellowship Award Partners Healthcare System Inc 399 Revolution Dr Ste 645 Somerville MA 021451465 042103561 501c3 49283 Postdoctoral Fellowship Rector & Visitors of The University Of Virginia 1001 North Emmet Street Charlottesville VA 22904 546001796 501c3 36100 Innovative Basic Science George Washington University Biostatistics Center 6110 Executive Blvd Rockville MD 20852 530196584 501c3 33000 RISE Federal Co-Support Award Partners Healthcare System Inc 399 Revolution Dr Ste 645 Somerville MA 021451465 042103561 501c3 13434 Junior Faculty Medical College of Wisconsin 8701 Watertown Plank Rd Milwaukee WI 53226 390806261 501c3 9000 Student Loan The University of North Carolina at Chapel Hill 104 Airport Dr Ste 2200 CD1350 Chapel Hill NC 27157 223849199 501c3 9000 Student Loan The Rockefeller University 1230 York Avenue New York NY 10016 135562308 501c3 308750 Early Investigator Award Icahn School of Medicine at Mount Sinai One Gustav L Levy Place Box 3500 New York NY 14850 150532082 501c3 308750 Early Investigator Award Columbia University 615 West 131st Street MC 8741 New York NY 10065 131924236 501c3 308750 Early Investigator Award Washington University 700 Rosedale Avenue Saint Louis MO 631121408 430653611 501c3 308750 Early Investigator Award University of Notre Dame 724 Grace Hall Notre Dame IN 46556 350868188 501c3 308750 Early Investigator Award Dana-Farber Cancer Institute 450 Brookline Avenue Boston MA 02215 042263040 501c3 308750 Early Investigator Award Yale University 155 Whitney Avenue Room 230 PO Box New Haven CT 06510 060646973 501c3 308750 Investigator New to Diabetes Research Award University of California Santa Barbara 3227 Cheadle Hall 3rd floor Santa Barbara CA 931062050 956006145 501c3 308750 Investigator New to Diabetes Research Award Joan & Sanford I Weill Medical College of Cornell University 1300 York Ave New York NY 10065 150532082 501c3 308750 Investigator New to Diabetes Research Award University of Illinois at Urbana-Champaign 1305 West Green Street Urbana IL 61801 376006007 501c3 308750 Investigator New to Diabetes Research Award University of Pennsylvania 3451 Walnut St P-221 Frankin Buildi Philadelphia PA 19104 231352685 501c3 308750 Investigator New to Diabetes Research Award University of California San Francisco 3333 California Street Ste 315 San Francisco CA 94143 946036493 501c3 308750 Investigator New to Diabetes Research Award Joslin Diabetes Center One Joslin Place Boston MA 02215 042203836 501c3 308750 Research Career Initiator Indiana University 107 S Indiana Avenue Bloomington IN 47405 356001673 501c3 308750 Research Career Initiator Jackson Laboratory 600 Main Street Bar Harbor ME 04609 010211513 501c3 308548 Early Investigator Award Children's Research Institute 111 Michigan Ave NW Washington DC 20010 521654453 501c3 302571 Early Investigator Award Stanford University 3145 Porter Drive Palo Alto CA 94305 941156365 501c3 300722 Research Career Initiator Cedars-Sinai Medical Center 8700 Beverly Blvd West Hollywood CA 90048 951644600 501c3 295826 Research Career Initiator University of Virginia 1001 N Emmet St Charlottesville VA 22904 546001796 501c3 289750 Research Career Initiator Duke University 324 Blackwell St Washington Bldg Durham NC 27701 560532129 501c3 286969 Research Career Initiator University of California San Diego 9500 Gilman Drive 0954 La Jolla CA 92093 956006144 501c3 218140 Research Career Initiator 119 Junior Faculty Stipend Award 2 18000 N/A Part I Line 2 The American Diabetes Association Research Foundation closely monitors the use of grant funds. Each grantee is required to submit an Annual Progress Report, which includes a scientific and a financial portion, 30 days after the end of each previously committed funding year. Each year of funding after the first is contingent upon approval of the Annual Progress Report and the availability of funds. If the complete report is not received within 90 days after the due date, the award will be terminated. After the completion of the final year of the grant, a Cumulative Final Report, which includes a scientific and financial report, is due within 60 days after the expiration date of the grant. If the complete final report is not received by the due date, the grantee will not be eligible for any future awards until the obligations for the award are complete. Part II Core awards fall into three primary program types general research awards, career development awards, and training awards. Research awards are designed to support different types of research projects, career development awards are designed to assist young investigators and junior faculty advance in their careers as they establish independence from their mentors, and training awards offer support for post-doctoral fellows as they gain research training experience. Targeted awards are offered periodically as we secure sponsor support, and are usually designed to request research proposals in specific topics. These are usually one time offerings that are not offered again. Overall, the core awards will consider any research topic, but targeted awards are focused on specific fields of research. Pathway awards fall into three main categories Initiator, Accelerator, and Visionary. Our Pathway grants support innovative basic, clinical, translational, epidemiological, behavioral, or health services research relevant to any diabetes type, diabetes-related disease state, or diabetes complication. The Association seeks exceptional candidates from a broad range of disciplines, including medicine, biology, chemistry, computing, physics, mathematics and engineering. All Pathway awards are available by institutional nomination only. Part III Line 1,2 The American Diabetes Association Research Foundation program provides support to undergraduate minority students and young scientists through Junior Faculty Stipend Awards and Minority Undergraduate Internships. The Foundations Junior Faculty Stipend Award is designed to support new faculty level investigators. The award supports an individuals salary and research project through an annual loan repayment. The Minority Undergraduate Internship award funds the training of an underrepresented minority undergraduate student as she/he gains valuable experience in diabetes research through a one year internship. false true false false false false false false false Robert A Gabbay Chief Scientific Medical Officer and Office of the CEO 453597 3614 23539 18850 499600 Charlotte M Carter Chief Financial Officer and Office of the CEO 321749 2266 19875 9662 353552 Tracey D Brown through October 6 20 Chief Executive Officer 467199 207014 373708 116123 22452 1186496 348133 Charles D Henderson Chief Development Officer and Office of the CEO 293056 1282 15295 1013 310646 Part I Line 3 The Office of the Chief Executive Officer, the Chief Financial Officer, the Chief Development Officer and the Chief Scientific Medical Officer of the American Diabetes Association the Association also serve in these roles for the American Diabetes Association Research Foundation the Foundation. The Principal Officers of the Board of Directors of the Association use an executive compensation committee, compensation studies, and an independent consultant to establish the compensation of the Chief Executive Officer. The Committee also reviews the compensation of the other staff to ensure compensation is within the guidelines set by the Committee. Part I Line 4b Tracey D. Brown, Chief Executive Officer, is compensated by the American Diabetes Association and contributed 95,823 to its supplemental 457f retirement plan. Part I Line 4b Robert Gabbay, Chief Scientific and Medical Officer, is compensated by the American Diabetes Association and contributed 16,733 to its supplemental 457f retirement plan. Part I Line 4b Charlotte M. Carter, Chief Financial Officer, is compensated by the American Diabetes Association and contributed 8,713 to its supplemental 457f retirement plan. Part I Line 4b Charles D. Henderson, Chief Development Officer, is compensated by the American Diabetes Association and contributed 7,747 to its supplemental 457f retirement plan. Rebekah J Walker PhD Grant Review Committee Member 130317 Junior Faculty Development Rebekah J Walker PhD Grant Review Committee Member 9000 Student Loan Part III Line 1 The Scientific Review Panel follows the requirements of the American Diabetes Associations conflict of interest policy when reviewing grant applications and providing funding recommendations. Members must recuse themselves for institutional, financial, and personal conflicts of interest. Panel members are not permitted to participate in the grant review process if they are listed as the principal investigator of an application under consideration. In addition, members may not participate in the review of a specific grant if the principal investigator is a close collaborator or close associate of the panel member. Cash and receivables 2021-12-31 8403794 Book Value 131623888 American Diabetes Association 2451 Crystal Drive Suite 900 Arlington VA 22202 501c3 true true false false true true true true false Part I Line 2a, 2b The board of directors of the American Diabetes Association Research Foundation, Inc. was composed entirely of members of the board of directors of the American Diabetes Association as of December 31, 2021. Form 990, Part I, Line 1 The American Diabetes Association Research Foundation, Inc. the Foundation secures major gifts and grants to fund diabetes-related research. Form 990, Part VI, Section A, Line 1a The main responsibilities and focus of the Foundations Board is to advance, support and promote charitable contributions by soliciting major gifts for the purpose of funding the American Diabetes Associations nationwide Research Program. The Board of Directors of the Foundation provides governance over the activities of the Foundation in accodance with the purposes, policies and procedures of the American Diabetes Association. The Board delegates to the Foundations Executive Committee responsibililty for management of the Foundation when the Board is not in session. The American Diabetes Association provides complete operational support to the Foundation including staff, facilities and administrative processes. The Foundations annual budget and audit process are governed by the American Diabetes Association Board of Directors and Audit Committee. Form 990, Part VI, Section A, Line 3,7a,7b The Foundations affairs are managed by the Foundation Board of Directors. The Board of Directors of the Foundation supervises, directs and controls the activities of the Foundation in accordance with the mission, purposes, policies and procedures of the American Diabetes Association. The Board delegates to the Foundations Executive Committee responsibility for management of the Foundation when the Board is in session. The American Diabetes Association provides complete operational support to the Foundation including staff, facilities and administrative processes. The Foundations annual budget and audit process are governed by the American Diabetes Association Board of Directors and Audit Committee. If a vacancy occurs among the Foundations officers for any reason, the Board of Directors of the American Diabetes Association shall fill such position for the unexpired portion of the term. Form 990, Part VI, Section B, Line 11b IRS Form 990 Review Process by the Governing Body The American Diabetes Association Research Foundation the Foundation draft IRS 990 is reviewed by the American Diabetes Associations management and BDO. The final and signed IRS Form 990 was provided to the Associations Board of Directors and the Foundations Board of Directors prior to filing with the IRS. Form 990, Part VI, Section B, Line 12c Managing a Conflict of Interest To identify potential conflicts of interest with appropriate due dilligence, the Foundations Officers, Directors and Members of the Grant Review Panel must annually disclose any potential conflicts of interest. The American Diabetes Associations Audit Committee and senior staff in Legal Affairs manage the disclosure and monitoring processes of the Board. The senior staff of the Associations Scientific Medical Division manage the disclosure and monitoring processes of the Grant Review Panel. Through review of the annual disclosure and review of the agendas of relevant Board, Committee and other meetings, appropriate efforts are made in advance of the meetings to identify potential conflicts of interest. Each person also has the responsibility to report his/her own conflicts of interest actual or perceived as those conflicts may arise during a meeting. Form 990, Part VI, Section B, Line 12c Research Grants Review Committee Conflict of Interest COI within the Research Grants Review Committee is managed through a written COI policy and through COI declarations signed both before and after the review cycle. The COI for grant reviewers is self-reported. The primary considerations addressed in the COI policy and program guidelines are as follows - Institutional Individuals are required to recuse themselves from reviewing grants for scientists at the same institution, including any institutions with which they may be negotiating employment. - Financial Individuals are required to recuse themselves from reviewing grants from which they stand to gain financially if the grant is awarded co-PI, collaborator, subcontracts, etc.. - Personal Individuals are required to recuse themselves from reviewing grants for investigators with whom they either have a personal or professional relationship collaborators, colleagues or personal friends, or a long standing professional or scientific disagreement that prevents them from unbiased review. Form 990, Part VI, Section B, Line 13 The American Diabetes Association has a written whistleblower policy that applies to the American Diabetes Association Research Foundation. Form 990, Part VI, Section C, Line 17 Alabama AL97-256 Alaska N/A Arizona10145 Arkansas N/A California CT81471 Colorado 2002-3003670 Connecticut CHR.0005084 Delaware N/A District of Columbia 981855 Florida CH1618 GeorgiaCH-001422 Hawaii N/A Idaho N/A Illinois CO01-025537 Indiana103829 Iowa N/A Kansas 177-257-350 Kentucky ID 45 Louisiana 34629813X Maine CO-1247 Maryland 102 Massachusetts Attorney General 029317 Michigan MICS 10326 Minnesota N/A Mississippi 100000294 Missouri CO- 021-87 Montana N/A Nebraska N/A Nevada N/A New Hampshire 5006New Jersey CH-0581900 New Mexico 1936418 New York 01-30-65 North Carolina SL000618 North Dakota 7894 Ohio 01-0239 Oklahoma 29417396 Oregon16402 Pennsylvania 21 Rhode Island 9500233 South Carolina 641South Dakota N/A Tennessee CO1919 Texas N/A Utah 6536093-CHAR Vermont N/A Virginia N/A Washington 1100167 West Virginia N/A Wisconsin3020-800 WyomingN/A Form 990, Part VI, Section B, Line 14 The American Diabetes Association has a written Document Retention and Destruction policy that applies to the American Diabetes Research Foundation. Form 990, Part VI, Section C, Line 19 Document Disclosure The following Research Foundation documents are not available on the American Diabetes Association website http//www.diabetes.org but are available upon written request to the American Diabetes Association Legal Affairs Department Board of Directors, audited financial statements, IRS Form 990, whistleblower policy, current bylaws, articles of incorporation and conflict of interest policy. Form 990, Part VII, Section A, Line 1,2,3 The Chief Executive Officer is a non-voting member of the Research Foundation Board of Directors. The Chief Executive Officer, the Chief Financial Officer, the Chief Development Officer and the Chief Scientific Medical Officer are compensated by the American Diabetes Association based on a standard average of 37.5 hours per week. Form 990, Part VII, Section A, Line 2,4 Tracey D. Brown ended her tenure as Chief Executive Officer on October 6, 2021. On that day, the Chief Financial Officer, Chief Development Officer and Chief Scientific and Medical Officer were appointed to the Office of the CEO by the Associations Board of Directors. Form 990, Part XI, Line 9 Other changes in net assets or fund balances of 572,737 reflect prior year research grant award refunds and forfeitures. Net assets were adjusted by 8,403,794 for the merger of ADA Research Foundation, Inc. into the American Diabetes Association as of December 31, 2021. Form 990, Part VI, Section A, Line 2 Pearson C. Cummin, III, Secretary-Treasurer, and Linda Cummin, Board of Directors, have a family relationship. Form 990, Part III, Line 4 Connected for Life Form 990, Part III, Line 4 Today, more than 133 million Americans in the United States have diabetes or prediabetes an invasive, unrelenting, and debilitating disease that spans all ages, geographic areas, and educational levels. This chronic disease targets children, the elderly, and minority populations more than others and costs the United States 327 billion each year in lost productivity. It is a global epidemic that contributes to heart disease, stroke, nerve and kidney disease, and vision loss. The American Diabetes Association ADA is the only organization dedicated specifically to the research, education, and advocacy required to improve the lives of the 37.3 million adults and children in the U.S. with diabetes and the 96 million people with prediabetes. For 81 years, we have been working on the front lines to educate at-risk populations protect the rights of people with diabetes at work, school, and other aspects of daily life pioneer clinical and research breakthroughs and foster a pipeline of the best and brightest scientists. Form 990, Part III, Line 4 The COVID-19 pandemic shined a very bright spotlight on diabetes as a public health crisis and on severe health inequities in our country. For people with diabetes, COVID-19 poses a much greater threat of severe complications, hospitalization, and even death. The ADA quickly adapted our resources, programs, and events in service to people living with diabetes and the health care professionals who treat them, and in 2021 we remained focused on ensuring people with diabetes could continue to get the care they needed to stay healthy and thrive.From research labs to the halls of the Capitol to the offices of health care practitioners to communities nationwide, the ADA is there. We are bending the curve to help people living with diabetes and their families thrive. Why Because we envision a life free of diabetes and all its burdens, which is fueled by our mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes. Form 990, Part III, Line 4 DIABETES RESEARCH Form 990, Part III, Line 4 Diabetes is an extremely complex disease, caused by a combination of various genetic and environmental factors that progressively lead to an inability to produce or effectively use insulin. The complexity of causes conspiring to diminish the bodys production or response to insulin, leading to high blood glucose blood sugar and eventual development of diabetes, makes finding a single cure particularly difficult. While a cure has been elusive, critical research efforts in recent decades have led to significantly improved patient care, resulting in fewer complications and better health outcomes for individuals with diabetes. Form 990, Part III, Line 4 As the only organization dedicated specifically to the research, education, and advocacy required to improve the lives of all people with diabetes, the ADA funds critical, innovative diabetes research and invests in promising scientists early in their careers. Our leadership in diabetes research extends back to the 1940s when Dr. Charles H. Best, one of four scientists credited with discovering insulin, provided the ADA with the framework and early leadership for a formalized diabetes research program. Form 990, Part III, Line 4 Since the ADA started its Research Programs in 1952, we have invested nearly 900 million in more than 4,850 diabetes research projects. In 2021 alone, we supported over 250 research projects at 123 leading research institutions across the U.S., all dedicated to progressing the fight against diabetes. Of these projects, 96 were led by in-training or early-career investigators. Form 990, Part III, Line 4 While we have learned much about diabetes, there is so much left to discover. The primary goals of the ADAs Research Program are to Support the highest-quality science across the broad spectrum of diabetes research. Support investigators early in their careers to encourage them to dedicate their efforts to diabetes research. Support innovative research with a high potential to have a significant impact for patients with diabetes. Form 990, Part III, Line 4 Peer Review Process. One of the factors that sets ADA funded research apart and ensures that we are supporting the very best science is peer review. Peer review is a process whereby grant applications are reviewed and evaluated by individuals who are experts in the field or peers of the individual submitting the grant. ADA grant applications undergo peer review by three or more volunteer experts who are themselves experienced researchers. Reviewers provide both a score and detailed comments regarding the strengths and weaknesses of each grant they review. Scores from all reviewers for each grant are averaged to arrive at a composite merit score that is then used to determine which grants to support. Form 990, Part III, Line 4 2021 Research Approach. The ADAs research strategy is targeted and laser focused, an approach that allows us to respond swiftly and decisively to the pressing needs of the diabetes community. For 2021 we prioritized action oriented research around health disparities, awarding funds to 11 projects including research on engaging grandmothers in care, using texting to improve diabetes management among people experiencing homelessness, and culinary education as a means for diabetes education. While we have a targeted approach to funding, we are also continuing to invest in our many career and training awards. Investing in early career diabetes professionals allows us to uplift, support, mentor, and secure the next generation of researchers as they prepare to care for the millions living with diabetes and prediabetes. Form 990, Part III, Line 4 COVID-19 ResearchIn 2021 the ADA saw the first results of the 1 million we invested in 2020 to investigate the link between the coronavirus and diabetes. These 10 research projects began to paint a clearer picture of why people with obesity and diabetes are at higher risk for hospitalization, serious outcomes, and death from the virus. Form 990, Part III, Line 4 Heres some of what weve learned about diabetes and COVID19 Form 990, Part III, Line 4 The coronavirus can infect and damage insulin-producing beta cells, causing them to produce significantly less insulin and more glucagon. This could account for higher rates of diabetes diagnoses among people infected with COVID19. Dr. Shuibing Chen, Weill Cornell Medicine Form 990, Part III, Line 4 When delivered to the nose and throat of an animal model, the coronavirus could later be found in the beta cells of the pancreas. These beta cells appeared to show the hallmarks of stress seen in the pancreases of people with type 2 diabetes. Dr. Senta Georgia, Childrens Hospital Los Angeles Form 990, Part III, Line 4 Individuals with metabolic syndrome of which diabetes is one factor were 3.4 times more likely to die from COVID19 and nearly 5 times more likely to be admitted to an ICU, need a ventilator, or develop acute respiratory distress syndrome. These findings suggest that the underlying inflammation seen with metabolic syndrome may be the driver that leads to more severe cases of COVID19. Dr. Joshua Denson, Tulane University Form 990, Part III, Line 4 In a laboratory setting, the coronavirus can directly infect fat and associated immune cells, eliciting a dramatic inflammatory response. This work tells us that the more fat cells a person has, the more of a reservoir the virus has to multiply, which could explain why people with obesity are at higher risk of severe illness and death from COVID19. Dr. Tracey McLaughlin, Stanford University Form 990, Part III, Line 4 While we have much more work ahead of us, these findings have opened important new avenues of research and helped identify potential therapeutic strategies which could ultimately reduce the burden of COVID19 in people with obesity and diabetes. Form 990, Part III, Line 4 Scientific SessionsHeld annually, Scientific Sessions exemplifies the ADAs leadership role in the global diabetes community while providing a critical platform for driving diabetes awareness. Scientific Sessions is the worlds largest scientific and medical meeting focused on the latest basic and clinical science research related to diabetes and its complications. Form 990, Part III, Line 4 For the second time in a row, the ADA conducted the five day conference completely online due to the COVID19 pandemic. Whether future meetings are in person, virtual, or hybrid, the Scientific Sessions remains a place for scientists to share their latest research findings, for physicians to learn how to best treat patients with diabetes, and for diabetes educators to exchange best practices for helping people manage the disease. The virtual 81th Scientific Sessions by the numbers 11,685 total attendees, 119 countries represented, 191 educational sessions, 850 presenters, 1,489 published abstracts, 1,098 eposter presentations Form 990, Part III, Line 4 Were Connected for Life. The American Diabetes Association is the nations leading voluntary health organization fighting to bend the curve on the diabetes epidemic to help people live a better life and thrive until we ultimately find a cure. The moving force behind the work of the American Diabetes Association is a network of more than 565,000 volunteers, their families and caregivers, a professional society of nearly 16,000 health care professionals, as well as more than 250 staff members. Form 990, Part III, Line 4 Diabetes has brought us all together, what we do next makes us Connected for Life. Learn more about the American Diabetes Association at diabetes.org. Form 990, Part III, Line 3 On December 31, 2021, the American Diabetes Association Research Foundation, Inc. merged into the American Diabetes Association and has therefore ceased making research grants. The research grant program will be continued by the American Diabetes Association. American Diabetes Association 2451 Crystal Drive Suite 900 Arlington VA 22202 131623888 See Part VII OH 501 c 3 7 N/A false American Diabetes Association Property Title Holding Corporation 2451 Crystal Drive Suite 900 Arlington VA 22202 541948004 See Part VII VA 501 c 2 N/A Association false false false true false false false false false false false false false true true true false false true false American Diabetes Association c 6220482 Contribution determined by management American Diabetes Association r 8403794 Net asset value Part II Line 1b The mission of the American Diabetes Association is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. Part II Line 2b The American Diabetes Association Property Title Holding Corporation was established to hold title to real property, collect the income therefrom, and remit to the American Diabetes Association. American Diabetes Association Research Foundation Inc 2451 Crystal Drive Suite 900 Arlington VA 22202 541734511 AMER